CAT #: 95000009
LymphoTrack® Dx Software - MiSeq®
The LymphoTrack Dx Software – MiSeq package is intended to be used for bioinformatics data analysis and visualization of raw FASTQ files from the Illumina MiSeq instrument when used with LymphoTrack Dx Assays.
The LymphoTrack® Dx Assays were designed to produce sequencing data that can be analyzed using the LymphoTrack Dx Software – MiSeq® package provided on the associated CD (Cat#: 9-500-0009). This CD includes detailed instructions for installation and use of the software package, as well as two essential tools for analysis:
- LymphoTrack Dx Data Analysis – MiSeq® (run with Microsoft Windows®)
- LymphoTrack Dx Visualization (run with Microsoft Excel®)
The MiSeq® sequencing run of samples prepared with LymphoTrack Dx Assays provide FASTQ files that can be easily processed into fully analyzed data using the LymphoTrack Dx Data Analysis – MiSeq® Application.
The data output can then be visualized in Microsoft Excel using the LymphoTrack Dx Visualization target-specific application. The following eight reports are generated:
- Read Summary
- Merged Read Summary
- VJ Sequence Frequency Graph
- VJ Usage
- VJ Usage Percent Graph
- VJ Usage Raw Graph
- VJ Sequence Frequency
- Unique Reads
These are in vitro diagnostic products and available in regions that accept CE-IVD products.
This product is covered by one or more patents and patent applications owned by or exclusively licensed to Invivoscribe, Inc., including United States Patent Number 7785783, United States Patent Number 8859748, United States Patent Number 10280462, European Patent Number EP 1549764B1 (validated in 16 countries, and augmented by related European Patents Numbered EP2418287A3 and EP 2460889A3), Japanese Patent Number JP04708029B2, Japanese Patent Application Number 2006-529437, Brazil Patent Application Number PI0410283.5, Canadian Patent Number CA2525122, Indian Patent Number IN243620, Mexican Patent Number MX286493, Chinese Patent Number CN1806051, and Korean Patent Number 101215194.
Use of this product may require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). Any necessary license to practice amplification methods or to use reagents, amplification enzymes or equipment covered by third party patents is the responsibility of the user and no such license is granted by Invivoscribe, Inc., expressly or by implication.
©2022 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.
ILLUMINA® and MISEQ® are registered trademarks of Illumina, Inc.